|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Histone deacetylase Inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B显示文摘 | Fuino L Bali P Wittmann S | 2003 | Mol Cancer Ther2003，2，10： | 1 |
| 2 | Cotreatment with the histone deacetyl-ase inhibitor suberoylanilide hydroxamic acid (SAHA) enhances imatinib- induced apoptosis of Bcr- Abl- positive human acute leukemia cells显示文摘 | Nimmanapalli R Fuino L Stobaugh C | 2003 | Blood2003，101，8： | 1 |
| 3 | Histone deacetylase in- hibitor LAQ824 down-regulates Her-2 and sensitizes hu- man breast cancer ceils to trastuzumab, taxotere, gem- citabine, and epothilone B 显示文摘 | Fuino L Bali P Wittmann S | 2003 | Mol Cancer Ther2003，，2： | 1 |
| 4 | Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer ceils to trastuzumab, taxotere, gemcitabine, and epothilone B 显示文摘 | Fuino L Bali P Wittmann S | 2003 | Mol Cancer Ther2003，2，10： | 1 |
| 5 | Cotreatment with the histone deacetylase inhibitor suberoylanilide hydrox amic acid (SAHA) enhances imatinib - induced apoptosis of Bcr- Ablpositive human acute leukemia cells 显示文摘 | Nimmanapalli R Fuino L Stobaugh C | 2003 | Blood2003，101，8： | 1 |
| 6 | Histone deacetylase inhibitor LAQ824 dawn-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab,taxotere,gemcitabine,and epothilone B显示文摘 | Fuino L Bali P Wittmann S | 2003 | Mol cancer Ther2003，2，10： | 1 |
| 7 | Cotreatment with the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) enhances imatinib-induced apoptosis of Bcr- Abl-positive human acute leukemia cells显示文摘 | Niramanapalli R Fuino L Stobaugh C | 2003 | Blood2003，101，8： | 1 |
| 8 | New piezoelectic crstal: Synthetic Fresboite(BaeTiSieO2) 显示文摘 | KMURA M FUINO Y KAWAMURA T | 1976 | Applied Physics Letters1976，29，4： | 1 |
| 9 | Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B 显示文摘 | Fuino L Bali P Wittmann S | 2003 | Mol Cancer Ther2003，2，10： | 1 |
| 10 | Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or-refractory chronic myelogenous leukemia-blast crisis cells显示文摘 | Fuino L Bali P | 2003 | Cancer Res2003，63，16： | 1 |
| 11 | Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or-refractory chronic myelogenous leukemiablast crisis cells显示文摘 | Nimmanapalli R Fuino L Bali P | 2003 | Cancer Res2003，63，16： | 1 |
| 12 | Cotreatment with the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) enhances imatinib-induced apoptosis of Bcr-Abl-positive human acute leukemia cells显示文摘 | Nimmanapalli R Fuino L Stobaugh C | 2003 | Blood2003，101，： | 1 |
| 13 | Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab,taxotere,gemcitabine,and epothilone B显示文摘 | FUINO L BALI P WITTMANN S | 2003 | Mol Cancer Ther2003，2，10： | 1 |
| 14 | Cotreatment with the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA)enhances imatinib-induced apoptosis of Bcr-Abl-positive human acute leukemia cells显示文摘 | Nimmanapalli R Fuino L Stobaugh C | | 0，，08： | 1 |
| 15 | Cotreatment with the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) enhances imatinib-induced apoptosis of Bcr-Abl-positive human acute leukemia cells显示文摘 | Nimmanapalli R Fuino L Stobaugh C | 2003 | Blood2003，101，8： | 1 |
| 16 | Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or -refractory chronic myelogenous leukemia-blast crisis cells显示文摘 | Nimmanapalli R Fuino L Bali P | 2003 | Cancer Res2003，63，16： | 1 |
| 17 | Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or-refractory chronic myelogenous leukemia-blast crisis cells显示文摘 | Nimmanapalli R Fuino L Bali P | 2003 | Cancer Res2003，63，16： | 1 |
| 18 | Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline显示文摘 | Talbot Konrad Wang Hoau-Yan Kazi Hala Han Li-Ying Bakshi Kalindi P Stucky Andres Fuino Robert L Kawaguchi Krista R Samoyedny Andrew J Wilson Robert S Arvanitakis Zoe Schneider Julie A Wolf Bryan A Bennett David A Trojanowski John Q Arnold | 2012 | EN2012，，4： | 1 |
| 19 | Histone deacetylase in- hibitor LAQ824 down - regulates Her - 2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B显示文摘 | FUINO L BALI P WITTMANN S | 2003 | Mol Cancer Ther2003，2，0： | 1 |
| 20 | Histone deacetylase inhibitor LAQ824 down regulates Her-2 and sensitizes human breast cancer cells to trastuzumab,taxotere,gemcitabine and epothilone B显示文摘 | Fuino L Bali P Wittmann S | 2003 | Mol Cancer Ther2003，2，10： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员